Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Encorafenib
Trade Name Braftovi
Synonyms LGX818
Drug Descriptions

Braftovi (encorafenib) is an inhibitor of Raf kinase with selective activity against BRAF V600E, resulting in growth inhibition (PMID: 24864047). Braftovi (encorafenib) is FDA approved for use in combination with Mektovi (binimetinib) in patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, and in combination with Erbitux (cetuximab) in patients with metastatic colorectal cancer with BRAF V600E(FDA.gov).

DrugClasses BRAF Inhibitor 20

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Alpelisib + AZD6482 + Binimetinib + Encorafenib AZD6482 Alpelisib Binimetinib Encorafenib 0 0
Alpelisib + AZD6482 + Encorafenib AZD6482 Alpelisib Encorafenib 0 0
Alpelisib + Cetuximab + Encorafenib Alpelisib Cetuximab Encorafenib 5 1
Alpelisib + Encorafenib Alpelisib Encorafenib 0 0
Alpelisib + Encorafenib + GSK2636771 Alpelisib Encorafenib GSK2636771 0 0
AZD6482 + Binimetinib + Encorafenib AZD6482 Binimetinib Encorafenib 0 0
AZD6482 + Binimetinib + Encorafenib + NVP-AEW541 AZD6482 Binimetinib Encorafenib NVP-AEW541 0 0
AZD6482 + Encorafenib AZD6482 Encorafenib 0 0
AZD6482 + Encorafenib + NVP-AEW541 AZD6482 Encorafenib NVP-AEW541 0 0
Binimetinib + Buparlisib + Encorafenib Binimetinib Buparlisib Encorafenib 0 1
Binimetinib + Capmatinib + Encorafenib Binimetinib Capmatinib Encorafenib 0 1
Binimetinib + Cetuximab + Encorafenib Binimetinib Cetuximab Encorafenib 1 3
Binimetinib + Encorafenib Binimetinib Encorafenib 14 15
Binimetinib + Encorafenib + Infigratinib Binimetinib Encorafenib Infigratinib 0 1
Binimetinib + Encorafenib + Nivolumab Binimetinib Encorafenib Nivolumab 0 2
Binimetinib + Encorafenib + Panitumumab Binimetinib Encorafenib Panitumumab 0 0
Binimetinib + Encorafenib + Ribociclib Binimetinib Encorafenib Ribociclib 0 2
Buparlisib + Encorafenib Buparlisib Encorafenib 1 1
Capmatinib + Encorafenib Capmatinib Encorafenib 0 1
Cetuximab + Encorafenib Cetuximab Encorafenib 5 2
Cetuximab + Encorafenib + LGK974 Cetuximab Encorafenib LGK974 0 1
Cetuximab + Encorafenib + Nivolumab Cetuximab Encorafenib Nivolumab 0 1
CGM097 + Encorafenib CGM097 Encorafenib 0 0
Dabrafenib + Encorafenib Dabrafenib Encorafenib 0 0
Encorafenib Encorafenib 7 5
Encorafenib + GSK2636771 Encorafenib GSK2636771 0 0
Encorafenib + GSK2636771 + unspecified IGF-1R antibody Encorafenib GSK2636771 unspecified IGF-1R antibody 0 0
Encorafenib + Infigratinib Encorafenib Infigratinib 0 1
Encorafenib + Panitumumab Encorafenib Panitumumab 0 0
Encorafenib + Pictilisib Encorafenib Pictilisib 0 0
Encorafenib + Ribociclib Encorafenib Ribociclib 1 2
Encorafenib + Trametinib Encorafenib Trametinib 4 0
Encorafenib + unspecified IGF-1R antibody Encorafenib unspecified IGF-1R antibody 0 0


Additional content available in CKB BOOST